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Background: Demographic and socioclinical factors affect adherence to dual anti-platelet therapy (DAPT) after percutaneous coronary intervention 
(PCI). DAPT cessation has been shown to increase stent thrombosis risk, recurrent myocardial infarction, and death. We investigated correlates of 
DAPT non-adherence after PCI in a large, multinational registry.
method: The PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) registry is a multicenter, prospective observational 
study of PCI patients. Modes of non-adherence were physician-guided discontinuation, interruption (surgery), or disruption (bleeding or non-
compliance). Independent variables were baseline demographics, comorbidities, and presentation. Predictors of non-adherence were identified using 
logistic regression. Model discrimination was assessed using receiver operating characteristic curve.
results: Among 5,033 patients, the incidence of non-adherence was 12.5% at 1-year. With multivariable adjustment, independent correlates of 
non-adherence were older, female gender, DES use, prior CABG, current smoking, and enrollment in the US (Table 1). This model yielded moderate 
discrimination for non-adherence by C-statistics of 0.67.
conclusion: In this multinational registry several clinical variables identified subsequent non-adherence at 1-year. This model may help identify 
patients who are more likely to stop DAPT and aid in risk prediction and clinical decisions at the time of PCI.
